Stoke Therapeutics (STOK, $11.65) was a top weekly loser, falling to $11.65 per share. Of the 920 stocks analyzed in the Biotechnology Industry throughout the week of April 4/11/2024 - 4/18/2024, 2024, of them () exhibited an Uptrend while of them (9) were in a Downtrend.